734 Endo Pill - blue & orange capsule/oblong, 19mm
Pill with imprint 734 Endo is Blue & Orange, Capsule/Oblong and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Endo Pharmaceuticals Inc.
Mycophenolate mofetil is used in the treatment of Organ Transplant, Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 734 Endo
Mycophenolate Mofetil
- Imprint
- 734 Endo
- Strength
- 250 mg
- Color
- Blue & Orange
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC)
- 60951-0734 (Discontinued)
- Inactive Ingredients
-
ammonia,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
potassium hydroxide,
povidone,
propylene glycol,
shellac,
ferric oxide yellow,
FD&C Blue No. 2,
ferric oxide red,
ferrosoferric oxide,
FD&C Red No. 3
Note: Inactive ingredients may vary.
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.